Um apelo

«Giant drug company Novartis is challenging Indian Patent law in the courts, to protect its exclusive right to sell medicines in India.
If they win, it will threaten India's ability to produce and export cheaper generic drugs, including HIV medicines, which benefit millions of people in developing countries.
This action is against an international agreement that allows developing countries to produce and import cheaper versions of medicines in the interests of public health. You can stop this action
Basta assinar e enviar um e-mail à empresa farmacêutica.